Walleye Capital’s Lifestance Health LFST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-31,400
Closed -$221K 4700
2025
Q4
$221K Sell
31,400
-300
-0.9% -$1.81K ﹤0.01% 3492
2025
Q3
$174K Buy
+31,700
New +$155K ﹤0.01% 3409
2025
Q2
Sell
-59,600
Closed -$397K 4814
2025
Q1
$397K Sell
59,600
-66,700
-53% -$507K ﹤0.01% 2747
2024
Q4
$931K Buy
+126,300
New +$906K ﹤0.01% 2448

Other funds holding LFST

Walleye Capital's LFST Position: Q1 2026 in Review

Walleye Capital sold out of Lifestance Health (LFST) in Q1 2026, closing a stake of 315 shares — an estimated $2.22K sold.

Walleye Capital first reported a position in LFST in Q2 2021 and held it in 7 quarters. The position peaked at $838K in Q3 2025. 228 funds tracked by Wall St. Rank hold LFST as of Q1 2026.

  • Walleye Capital reported no remaining Lifestance Health position as of Q1 2026 after selling out during the quarter.
  • Walleye Capital sold 315 Lifestance Health shares in Q1 2026, an estimated $2.22K.
  • Walleye Capital first reported a position in Lifestance Health in Q2 2021 and held it in 7 quarters.
  • Walleye Capital's Lifestance Health position peaked at $838K in Q3 2025.
  • 228 funds tracked by Wall St. Rank held Lifestance Health as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.